I’m passionate about transforming healthcare through ethical data innovation, strategic leadership, and empowering the next generation of women in tech and science. With over 20 years of experience in healthcare analytics, AI, and data governance, I’ve led global teams, shaped operational strategy, and served on advisory boards and nonprofit foundations. Whether through mentoring, publishing, or speaking on global stages, I’m committed to advancing equitable, data-driven solutions that improve lives and elevate leadership across industries.

I’m a seasoned clinical research professional with over two decades of experience supporting and leading clinical trials across all phases and therapeutic areas. My journey has taken me through top pharmaceutical organizations like Bristol Myers Squibb, GSK, Karuna Therapeutics, and AstraZeneca, where I’ve specialized in clinical operations, regulatory compliance, and team development. I’m passionate about building efficient systems, mentoring others, and contributing to work that ultimately improves patient lives.

After nearly three decades in healthcare and higher education, I’ve had the privilege of serving in roles that span clinical care, academic leadership, and strategic innovation. I’m passionate about building systems that elevate nursing education, drive student success, and create meaningful impact. Here is my biography.

Dr. Kashinath Yadalam is a seasoned psychiatrist and clinical research leader with over 40 years of experience advancing treatments for psychiatric and neurological disorders. As Owner and Medical Director of Lake Charles Clinical Trials, he has built a respected institution known for its high standards in ethical, safe, and innovative clinical research. A Distinguished Life Fellow of the American Psychiatric Association and a Certified Physician Investigator, Dr. Yadalam has collaborated with pharmaceutical companies, academic institutions, and regulatory bodies to design and oversee groundbreaking trials in psychopharmacology. His career reflects a lifelong commitment to improving mental health care through scientific rigor, compassionate practice, and academic excellence.

Dr. Violanda Grigorescu is a globally recognized leader in public health, clinical science, and biomedical informatics with over 40 years of experience spanning federal, state, and international roles. She has held senior positions at the NIH, CDC, and Michigan Department of Community Health, where she led transformative initiatives in maternal and child health, health data infrastructure, and epidemiologic research. Known for building collaborative ecosystems across agencies and disciplines, Dr. Grigorescu has pioneered groundbreaking programs integrating AI, FHIR standards, and advanced analytics to improve health outcomes and policy. Her career reflects a rare blend of clinical expertise, strategic leadership, and a deep commitment to equity and innovation in healthcare systems.

Christopher Roche is a seasoned medical device executive with over 23 years of experience driving innovation in orthopedic technology and global commercialization. As Senior Vice President of Extremities at Exactech, he has led the division’s transformation into a $200 million business while contributing over 140 peer-reviewed publications and securing 38 patents. A member of the AIMBE College of Fellows and a recognized thought leader, Christopher blends deep biomedical engineering expertise with strategic vision and a passion for mentoring and global collaboration.

Dr. Gilles Besin is a visionary scientific executive whose career spans over 20 years at the forefront of RNA therapeutics and immunology. As Chief Scientific Officer at Orbital Therapeutics, he is redefining the landscape of next-generation RNA medicine through groundbreaking work in mRNA and circular RNA platforms. From leading vaccine development programs to spearheading major biotech acquisitions, Dr. Besin blends deep scientific expertise with strategic insight, positioning him as a driving force in translating cutting-edge research into real-world therapeutic solutions.

Dr. Hassan Razvi is a globally respected healthcare innovator and urological surgeon with over three decades of experience advancing medical research, device development, and clinical excellence. Known for his leadership in early-stage product innovation through to clinical trials, he has contributed extensively to the global medical community through board service, international collaboration, and impactful communication. Dr. Razvi's ability to translate complex clinical insights into strategic direction makes him a valuable advisor to companies aiming to grow and innovate in the healthcare, pharmaceutical, and medical device industries.

I'm excited to share my professional biography, capturing the journey I've taken across HEOR, pharmaceutical innovation, real-world evidence, and health policy. With over 20 years of experience in building value through data, strategic insight, and collaborative leadership, I'm proud to continue this work alongside inspiring teams and partners.

Dr. Michael E. Kuligowski, MD, PhD, MBA, is a globally recognized physician-executive with over four decades of leadership in dermatology, clinical development, and pharmaceutical strategy. With a distinguished career spanning Europe and the United States, he has led the development and approval of numerous dermatologic therapies, including Opzelura® for atopic dermatitis and vitiligo. Known for his scientific rigor, strategic foresight, and collaborative leadership, Dr. Kuligowski continues to influence the future of dermatologic innovation through executive roles, advisory board appointments, and pro-bono consulting in the life sciences sector.

Dr. Larrye Ellis Loss, PharmD, MBA, is a global pharmaceutical executive and consultant with over 40 years of experience leading clinical development, medical affairs, and strategic operations across the life sciences industry. With a distinguished career at AstraZeneca and current advisory work through his own consultancy, Larrye brings deep expertise in drug development, regulatory strategy, and cross-functional leadership. He is known for his integrity, global perspective, and commitment to mentoring the next generation of healthcare professionals. Passionate about service, he also dedicates his time to nonprofit leadership and disaster relief with the American Red Cross.

I am excited to share my executive biography, highlighting my journey in oncology, clinical research, and medical affairs over the past 25 years. From my work as a medical science liaison to my leadership in pharmacy education and healthcare consulting, I have been committed to advancing patient care, scientific innovation, and medical education. If you're interested in learning more about my background, expertise, and contributions to pharmaceutical sciences and healthcare strategy.

Matthew Smollin, PharmD, is an accomplished leader in medical affairs and clinical innovation with over 15 years of clinical experience and a decade of industry expertise spanning clinical research, regulatory strategy, and team leadership. As Vice President of Medical Affairs at Karius, Inc., he directs medical and scientific strategies, guiding breakthrough advancements in molecular diagnostics while navigating complex FDA and Medicare regulatory processes. Throughout his career, he has successfully built and managed high-performing teams, fostered strong relationships with key opinion leaders, and played a pivotal role in clinical trial design, publication strategy, and scientific engagement. A respected speaker and thought leader, Dr. Smollin’s expertise in infectious disease diagnostics and next-generation sequencing has shaped industry best practices and advanced clinical innovation. His dedication to scientific excellence, strategic vision, and ability to translate complex medical insights into impactful solutions make him a driving force in the evolution of precision medicine and diagnostic technologies.

I’m excited to share my executive biography, detailing my 34-year journey in finance, accounting, and business transformation across the pharmaceutical, clinical research, and healthcare industries. I’m passionate about leading change, building trust, and driving financial excellence. If you’re looking for strategic board leadership in finance and operations, let’s connect!

Peter Payne is a highly accomplished executive with over 30 years of leadership experience in the pharmaceutical, biotechnology, and contract research organization (CRO) industries. Known for his integrity and results-driven approach, Peter has successfully led organizations through periods of significant growth and transformation. With deep expertise in drug development, clinical trials, and corporate strategy, he has built a strong reputation for driving innovation and strategic partnerships. His leadership spans notable roles, including Vice President at Optum, President of Gennaker Bio, and CEO at multiple biotech companies. Peter’s ability to communicate complex strategies and foster cross-functional collaboration has made him a respected figure in the life sciences industry.

With over 38 years of experience in clinical research, pharmaceuticals, and healthcare marketing, I’m proud to share my professional biography highlighting my journey and contributions to the healthcare industry. From leading global projects to advocating for causes close to my heart, my career reflects a commitment to excellence and innovation. Here is my biography.